Lab guide · Neuropeptides
What Is Oxytocin? Cyclic Neuropeptide Research Overview
What is Oxytocin? It is a nine-residue cyclic peptide hormone and neuropeptide, Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, closed into a ring by a disulfide bond between Cys1 and Cys6. This guide covers its structure, its place as the first peptide hormone to be sequenced and synthesised, its receptor signalling and how it differs from vasopressin.
Key takeaways
- Oxytocin is a cyclic nonapeptide amide with a Cys1-Cys6 disulfide, formula C43H66N12O12S2, molecular weight 1007.2 g/mol and CAS number 50-56-6.
- It was the first peptide hormone to be sequenced and synthesised, by Vincent du Vigneaud in 1953, work recognised by the 1955 Nobel Prize in Chemistry.
- It signals through a single Gq-coupled receptor, the oxytocin receptor, via phospholipase C, IP3 and intracellular calcium.
- Oxytocin is the active ingredient of licensed obstetric medicines; that approval does not apply to research-grade material or to its behavioural research.
What is Oxytocin?
So, what is Oxytocin? Oxytocin is a hypothalamic nonapeptide hormone and neuropeptide. A review of its basic science notes it was the first peptide hormone to be sequenced and synthesised, by Vincent du Vigneaud in 1953, and that he was awarded the Nobel Prize for it. It is made in the hypothalamus and released from the posterior pituitary, and it also acts within the brain.
Research use only. This overview summarises published laboratory and animal research. Baltic Peptides supplies this compound for in-vitro and preclinical research by qualified researchers; it is not a medicine and is not for human or veterinary use.
Chemical structure and specifications
| Property | Value |
|---|---|
| Sequence | H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 (disulfide Cys1-Cys6) |
| Length | 9 residues, C-terminal amide |
| Molecular formula | C43H66N12O12S2 |
| Molecular weight | 1007.2 g/mol (average); 1006.436 Da monoisotopic, calculated |
| CAS number | 50-56-6 (acetate salt: 6233-83-6, supplier-listed) |
| PubChem CID | 439302 |
The values match the PubChem record, and the sequence with its ring closure reproduces the formula and mass. In his Nobel lecture, du Vigneaud noted that oxytocin introduced a new ring system to nature, a 20-membered ring involving a disulfide linkage. A six-residue ring carries a three-residue amidated tail (Pro-Leu-Gly-NH2).
Discovery and research history
Du Vigneaud and colleagues determined the structure of oxytocin and then confirmed it by synthesis. The synthetic product behaved identically to natural oxytocin in physical, chemical and biological comparisons, which justified the conclusion that the synthetic octapeptide amide is oxytocin. The work led to the 1955 Nobel Prize in Chemistry.
The oxytocin receptor was cloned later and a considerable literature developed on its expression in the uterus, brain and other tissues, summarised in a review of the oxytocin receptor.
Mechanism: oxytocin receptor signalling
Receptor and pathway
Oxytocin has one receptor type, which belongs to the rhodopsin-type class I G protein-coupled receptor family and couples through Gαq/11 to phospholipase C. PLC cleaves PIP2 into inositol trisphosphate (IP3) and diacylglycerol (DAG), which release intracellular calcium and activate protein kinase C (review).
Selectivity
Oxytocin differs from the closely related vasopressin at only two positions, 3 and 8 (Ile3 and Leu8 in oxytocin; Phe3 and Arg8 in vasopressin). This small change shifts receptor preference, and oxytocin binds the vasopressin V1a receptor more weakly, so receptor selectivity is a recurring design question in research.
Main research areas
- Receptor pharmacology: OXTR binding and signalling assays, and comparison with vasopressin-receptor ligands.
- Smooth-muscle physiology: uterine and myometrial contraction assays.
- Social neuroscience: social recognition, affiliative and pair-bonding paradigms in rodents.
- Stress and cardiovascular models: interaction with the HPA axis and OXTR expression in the heart and vessels.
What published studies actually show
Oxytocin has a larger human record than most peptides in this series, but of very different kinds. The table separates them.
| Evidence type | What is reported |
|---|---|
| Chemical facts | Structure, ring closure and synthesis are established (Nobel 1955). |
| Receptor biology | Gq/PLC/IP3 signalling is the major mechanism described in reviews. |
| Obstetrics | The 2010 review describes oxytocin as a stimulant widely employed to induce or augment labour, and it is the active ingredient of licensed obstetric medicines. |
| Behavioural research | Rodent social-behaviour findings are extensive; extending them to humans is debated and the reproducibility of some behavioural findings has been questioned. |
A licensed obstetric medicine is a defined pharmaceutical product with its own indication. It does not apply to research-grade oxytocin, and it says little about the behavioural literature.
Scientific limitations and open questions
- Oxytocin has a short circulating half-life and does not cross the blood-brain barrier readily, which complicates interpretation of central effects.
- Behavioural findings in rodents have not always been reproduced in humans.
- Receptor cross-reactivity with vasopressin receptors confounds some experiments.
- Approval of obstetric products does not extend to research-grade material.
Analytical and laboratory considerations
Mass spectrometry should show the cyclic peptide at about 1007.2 Da with the disulfide intact. The linear reduced form would be about 2 Da heavier, so mass distinguishes ring-closed from ring-open forms. Reducing agents such as DTT break the disulfide and remove activity, so buffers should not contain them. Oxytocin is also deamidation- and dimerisation-prone, which HPLC should resolve.
See how to store peptides and the guide to reading a peptide COA. Batch reports are on the COA page, and formats are on the Oxytocin product page.
Sources and further reading
- Oxytocin: crossing the bridge between basic science and pharmacotherapy (2010 review). PMC full text
- du Vigneaud V. Nobel Lecture (1955): A trail of research on sulfur-containing compounds. Nobel Prize
- The oxytocin receptor (review). PubMed
- PubChem compound record for oxytocin (CID 439302). PubChem
All Baltic Peptides products are supplied strictly for laboratory research use. They are not medicines, supplements or food and are not for human or animal use. This article summarises published research for educational purposes only and does not describe any use in people.
FAQ
Common questions
What is Oxytocin?
What is the molecular weight and CAS number of Oxytocin?
Who first synthesised Oxytocin?
How is Oxytocin different from vasopressin?
How does the oxytocin receptor signal?
Why does the disulfide bridge matter for Oxytocin?
Is Oxytocin an approved medicine?
Keep reading
Related reading
Oxytocin
Current batches, formats and the COA for Oxytocin.
What is Kisspeptin-10?
A hypothalamic peptide acting on a different Gq-coupled receptor.
What is DSIP?
A linear nonapeptide with an unresolved biological role.
Research-grade Oxytocin, tested before it ships
Independent HPLC and mass spec results for every batch, dispatched from the EU.
